European Investment Bank

Orano is a leading global company based in Courbevoie, France, specializing in nuclear power and renewable energy solutions. The company offers a comprehensive range of services covering every stage of the nuclear fuel cycle, including reactor design, construction, and operational support. With a strong emphasis on safety and advanced technology, Orano is committed to supplying low-carbon power generation solutions. Additionally, it engages in renewable energy initiatives through partnerships aimed at developing high-tech solutions. As energy demand increases and the need for sustainable practices intensifies, Orano focuses on creating cleaner energy alternatives that contribute to reducing greenhouse gas emissions. The company aims to enhance transparency, coherence, and efficiency in its operations while preparing for the future energy landscape.

Infrastrutture Wireless Italiane S.p.A., established in Milan, Italy, specializes in constructing, operating, and managing wireless network infrastructure across Italy. The company hosts transmission equipment for major operators on its approximately 23,000 sites, contributing significantly to national wireless telephony coverage. It offers integrated hosting services including antenna framework, cabling, power supply systems, site management, maintenance, and fiber optic connections. Additionally, Infrastrutture Wireless Italiane designs and constructs new sites and creates indoor/outdoor coverage using micro cells and distributed antenna systems for various locations such as stations, hospitals, and stadiums. Its primary competitor is Cellnex.

Universal Diagnostics, S.L. is a biomedicine company based in Seville, Spain, with an additional office in San Francisco, California. Founded in 2012, the company focuses on developing blood-based tests for the early detection of various cancers, including colorectal, lung, liver, pancreatic, and gastric cancers. Its diagnostic platform utilizes proprietary methylation marker panels, allowing for minimally invasive testing that can be performed using standard laboratory equipment. The first test developed by Universal Diagnostics is aimed at colorectal cancer screening, identifying individuals who may require further examination through colonoscopy. The company emphasizes the importance of early detection, as this can significantly improve treatment options and survival rates. To advance its research and development efforts, Universal Diagnostics collaborates with international research institutions, hospitals, universities, and biobanks worldwide.

Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Amadix is a biotechnology company focused on the development and commercialization of innovative cancer diagnostic technologies that address unmet medical needs in oncology. The company aims to enhance early cancer detection through non-invasive methods, significantly improving patient outcomes and reducing the complications associated with traditional invasive procedures like tumor biopsies. Amadix's flagship product, Colofast, is a non-invasive blood test designed for the screening of colorectal cancer and advanced adenoma diagnosis, targeting the high mortality rate associated with this disease. The company is committed to validating its products through international multicenter studies to ensure clinical efficacy before global commercialization. The team at Amadix comprises experienced professionals with extensive backgrounds in oncology diagnostics, the pharmaceutical industry, and biotechnology, supported by an independent board of advisors with deep expertise in oncology and diagnostics, guiding the company's strategic and commercial efforts.

Royal Schiphol Group N.V. is the owner and operator of Amsterdam Airport Schiphol, the national airport of the Netherlands, as well as other airports including Rotterdam The Hague Airport and Lelystad Airport. The company manages and develops airport operations, providing essential services and facilities to airlines, travelers, handling agents, and logistics providers. It also grants concessions for various shops, restaurants, and entertainment options within the airport, while operating its own retail spaces and car parks. Additionally, Royal Schiphol Group develops and manages properties related to airport activities, offering various locations and rental agreements for businesses and logistics service providers. Established in 1958 and headquartered in Schiphol, the company plays a crucial role in aviation and transportation in the Netherlands and beyond.

Samotics is a Dutch technology company that specializes in an AI-powered condition monitoring platform aimed at enhancing the availability of industrial electric motors and rotating equipment. By utilizing data from sensors and operational systems, Samotics' solution offers predictive insights that help companies identify and address potential equipment failures before they occur. This proactive approach enables organizations to reduce unplanned downtime, lower operational costs, and minimize energy waste. The company serves a diverse range of global industrial clients, including notable names such as Anglian Water, ArcelorMittal, and Nobian, helping them optimize their operations and improve the efficiency of their critical equipment.

Median Technologies SA specializes in the development and marketing of software products and platforms for medical image analysis, primarily focusing on oncology. Founded in 2002 and headquartered in Valbonne, France, the company operates internationally, offering solutions that enhance the diagnosis and treatment of cancer patients. Its key products include iBiopsy, an imaging platform that utilizes AI for biomarker identification, and iSee, which supports image analysis and management in clinical trials. Additionally, Median provides a range of imaging contract research services, including study startup, data management, and scientific consulting to optimize clinical trials. The company collaborates with a contract research organization and Canon to enhance its imaging technologies and services, aiming to improve patient care and streamline drug development processes.

NXP Semiconductors N.V. is a prominent supplier of high-performance mixed-signal semiconductor products, headquartered in Eindhoven, the Netherlands. Founded in 2006, the company offers a diverse product portfolio that includes microcontrollers, application processors, communication processors, and various wireless connectivity solutions such as Bluetooth, Wi-Fi, and Near Field Communications. NXP's technology is integral to multiple applications across automotive, industrial, Internet of Things, mobile, and communication infrastructure sectors. The company has established a significant presence in the automotive market, providing essential components for powertrains, infotainment systems, and safety systems. Additionally, NXP maintains operations in over 25 countries and has formed strategic partnerships, including collaboration with Amazon Web Services to enhance connected vehicle solutions.

Formo is a pioneering cellular agriculture company based in Europe that specializes in creating animal-free dairy products. By utilizing precision fermentation, Formo develops real, nature-identical milk proteins, allowing for the production of clean dairy alternatives. The company aims to provide sustainable and healthy options for consumers, particularly those seeking vegan food products. Through innovative biotechnology, Formo transforms nutrients into dairy proteins, contributing to a more equitable and environmentally friendly approach to dairy consumption.

Energias de Portugal (EDP) is a prominent global energy company based in Lisbon, Portugal, founded in 1976. It operates primarily in the electricity and gas sectors, offering services in generation, distribution, and trading. EDP is one of the largest energy operators in the Iberian Peninsula and ranks as the third-largest producer of wind energy in the region. The company emphasizes value creation, innovation, and sustainability, reflecting its commitment to customers, society, and the environment. EDP's diverse workforce spans multiple continents, fostering a culture that respects the various markets in which it operates. Additionally, EDP is recognized for its performance in transparency and sustainability, as evidenced by its inclusion in the Dow Jones Sustainability Indexes.

Emerging Markets Global Advisory is an investment bank based in London, United Kingdom, specializing in advisory services for financial institutions, institutional investors, and large-cap and middle-market companies across various industries. The firm provides a comprehensive range of investment banking services, including mergers and acquisitions advisory, corporate finance, and capital raising, encompassing both debt and equity. Additionally, it offers expertise in leveraged buyouts, restructurings, valuation analysis, recapitalizations, and divestitures. Emerging Markets Global Advisory serves clients in diverse sectors such as financial services, manufacturing, transportation, agriculture, food, energy, and communications, making it a versatile partner for organizations seeking strategic financial guidance.

ERG is a leading wind power operator in Italy and ranks among the top ten in Europe, specializing in the production of electricity from clean, renewable, and sustainable sources. With a legacy of 80 years, the company harnesses a combination of wind and solar energy, alongside hydroelectric and natural gas operations. ERG's wind power initiatives are managed by its subsidiary, ENG Renew, which focuses on the development, construction, and operation of wind assets. Additionally, ERG Power Generation oversees its hydroelectric and natural gas operations, which include various plants, dams, reservoirs, and a pumping station. This diversified approach allows ERG to supply electricity to markets across Europe while maintaining a commitment to sustainability.

Distribuție Energie Electrică Romania distributes and supplies electrical energy in northern Transylvania, Romania.

Cellectis S.A. is a clinical-stage biotechnological company based in Paris, France, focused on developing innovative immuno-oncology therapies using gene-edited T-cells. The company specializes in allogeneic Chimeric Antigen Receptor T-cell (CAR-T) products, with a portfolio that includes several product candidates targeting various hematologic malignancies. Notable candidates include UCART19, aimed at treating CD19-expressing hematologic cancers such as acute lymphoblastic leukemia; UCART123 for acute myeloid leukemia; and UCARTCS1 and ALLO-715 for multiple myeloma. In addition to its therapeutic efforts, Cellectis also produces high oleic soybean oil and other soybean products, as well as fiber wheat. The company collaborates with various strategic partners, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to advance its mission of eradicating cancer through cutting-edge gene-editing technologies.

Marinomed Biotech AG is a biopharmaceutical company based in Vienna, Austria, specializing in the development of innovative therapies for respiratory and ophthalmological diseases. Founded in 2006, the company operates primarily through two technology platforms: Marinosolv and Carragelose. Marinosolv enables the creation of stable aqueous formulations for poorly soluble compounds, enhancing their bioavailability and therapeutic efficacy, while Carragelose offers antiviral solutions aimed at respiratory viruses. Marinomed's product portfolio includes nasal sprays, throat sprays, and lozenges designed to block viruses and alleviate symptoms associated with conditions such as cough, cold, influenza, and allergic rhinitis. The company collaborates with partners to market its products globally, focusing on improving treatment options for patients with sensitive tissues in the nose and eyes.

Enpal GmbH is a Berlin-based company founded in 2017 that specializes in providing comprehensive renewable energy solutions, primarily through the installation and operation of solar panels for residential electricity generation. The company offers a range of products, including solar panels, batteries, wallboxes, heat pumps, and energy management systems, catering to customers in Germany and Italy. Enpal initially adopted a sales-based model but successfully transitioned to a lease model that requires no upfront payment and includes installation, insurance, and maintenance services. This approach has resulted in significant growth, with over 60,000 solar PV systems installed and revenues exceeding 400 million euros as of 2022. Enpal employs more than 1,000 team members, including over 200 local installer teams, and has opened several satellite offices to enhance customer service across its markets. The company has received numerous awards for its contributions to sustainability and customer service, positioning itself as a leader in the solar PV installation sector in Germany.

GEWOBA Aktiengesellschaft Wohnen und Bauen is a prominent real estate company based in Bremen, Germany, founded in 1924. The company specializes in residential real estate management, acquisition, construction, urban development, leasing, and brokerage services. In addition to its real estate operations, GEWOBA also oversees the Gewoba Foundation, established in 1999, which focuses on providing commercial and residential rental properties, along with property management and development services. The foundation's assets are managed by a dedicated board of directors, ensuring effective governance and operational oversight.

Vay is a Berlin-based deep technology company that is on track to launch the first driverless, safety-certified, commercial fleet on European public streets. The company aims to revolutionize urban transportation by enabling remote-controlled cars, offering a safer, more efficient solution for ride-hailing and vehicle-sharing services. Vay’s unique approach blends the advantages of self-driving technology with human supervision to ensure safety and adaptability in complex driving environments. Their goal is to reduce urban congestion, cut emissions, and make mobility more sustainable while providing a seamless transportation experience for users.

NVision Imaging Technologies GmbH, founded in 2015 and based in Ulm, Germany, specializes in the development and commercialization of innovative imaging and sensing applications grounded in quantum physics. The company has created a platform that polarizes natural metabolites, enabling their use as agents for imaging tumor metabolism through magnetic resonance imaging (MRI). This technology transforms standard magnetic resonance spectrometers into tools capable of assessing human metabolism, thereby enhancing the precision of cancer diagnostics and facilitating real-time monitoring of patient responses to therapy. By leveraging advances in quantum physics, NVision aims to make significant strides in the medical imaging and diagnostics sector.

Fab'entech, founded in 2009 in Lyon, France, is a biopharmaceutical company that specializes in developing and commercializing innovative passive immunotherapeutic solutions. The company focuses on specific polyclonal immunoglobulins [F(ab’)₂] to address emerging infectious diseases and certain drug intoxications. By utilizing highly purified fragments of horse-specific polyclonal immunoglobulins, Fab'entech provides healthcare institutions with effective treatments for emergency situations. As a member of the LyonBiopôle cluster, the company is positioned within a network that fosters biotechnological advancements in the region.

Nexi Payments, headquartered in Milan, Italy, specializes in electronic money and payment services. It facilitates transactions between banks, merchants, and consumers by offering a range of services, including merchant acquiring (POS management), card issuing (credit, debit, and pre-paid), and digital banking solutions. Nexi partners with banks to provide these services, aiming to modernize Italy's payment infrastructure and promote a cashless society.

Cyprus University of Technology (CUT) provides education and research in subjects that create significant economic, technological, and scientific developments. The University established in 2004, is a public institution located in Limassol that offers a comprehensive educational experience. CUT is known for providing quality education and conducting research in areas that contribute to economic, technical, and scientific advancements. With a focus on applied research, the university addresses significant challenges in science, technology, and knowledge, aiming to benefit both the state and society.

Deutsche Glasfaser Holding GmbH, founded in 2012 and based in Borken, Germany, specializes in the planning, construction, and operation of fiber optic networks, particularly targeting rural and suburban areas. As a significant player in the broadband telecommunications sector, the company aims to facilitate nationwide fiber optic expansion, contributing to Germany's digital advancement. Deutsche Glasfaser focuses on delivering fast and cost-effective fiber-to-the-home (FTTH) connections in collaboration with municipalities, positioning itself as a leader in innovative planning and construction processes. With substantial backing from experienced investors, the company has established a strong financial foundation, making it one of the most robust providers in the German market.

Stark Future, founded in 2019 by Anton Wass and Paul Soucy, is a Spanish company with Swedish origins, located near Barcelona, Catalonia. The company focuses on developing electric motorcycles with the goal of reducing emissions and environmental impact through innovative technology and sustainable materials. Its first product, the Stark VARG, launched on December 14, 2021, features an 80-horsepower electric engine, a smartphone dashboard, and an app for bike setup. The VARG quickly gained popularity, achieving €9 million in advance sales within the first 24 hours and over 5,000 units sold in less than two months. Stark Future is committed to leading the transition to a sustainable motorcycle industry while providing high-performance options for environmentally conscious riders. The team's expertise includes former motocross world champion Sebastien Tortelli, who serves as the test manager, contributing to the company's commitment to excellence and innovation in electric motorcycle technology.

Acba Bank is a financial institution that offers a range of banking services to individuals, businesses, and farmers in Armenia. Established with the support of international partners, the bank focuses on providing agricultural loans, facilitating money transfers, and offering foreign exchange services. Additionally, it provides leasing options and community funding, aiming to support the local economy and enhance agricultural development. Acba Bank plays a crucial role in financing Armenian agriculture, drawing on its foundation as a cooperative bank inspired by European models.

Sunprime is an independent power producer based in Italy, founded in 2020 by Fulvio Mariani. The company specializes in the development of photovoltaic solar projects, focusing on providing no-cost installation of solar panels on rooftops. This innovative business model allows customers to enhance their sustainability efforts and increase the value of their properties without any upfront investment. With a team experienced in engineering and construction, Sunprime is actively expanding its portfolio of solar initiatives across the country.

Protembis GmbH, founded in 2017 and based in Aachen, Germany, specializes in the manufacture of surgical equipment aimed at enhancing the safety of transcatheter aortic valve replacement (TAVR) procedures. The company has developed the ProtEmbo System, an intra-aortic filter device designed to mitigate the risk of cerebrovascular events during TAVR by deflecting embolic material away from the cerebral circulation. This innovation addresses a significant complication associated with TAVR, which has become a preferred treatment for patients with valvular heart disease, particularly as the procedure is increasingly performed on younger and lower-risk individuals. By minimizing the risk of brain injury, Protembis aims to improve patient outcomes and reduce healthcare costs related to surgical complications.

Elektrodistribucija Srbije doo Belgrade is a Serbian Public Electric Utility Company.

Nyxoah S.A. is a health-technology company based in Mont-Saint-Guibert, Belgium, established in 2009. The company specializes in developing and commercializing innovative solutions for treating sleep disordered breathing conditions, particularly moderate to severe obstructive sleep apnea (OSA). Its primary product, the Genio system, is a user-centered, bilateral neurostimulation therapy that has received CE-Mark validation. OSA is a prevalent condition linked to significant health risks, including increased mortality and various comorbidities such as cardiovascular diseases, depression, and stroke. Nyxoah aims to address these critical health challenges through its advanced therapeutic offerings.

Tele2 is a prominent telecommunications operator serving approximately 15 million customers across ten countries, including Sweden and the Baltic markets. Established in 1993 by Jan Stenbeck, Tele2 initially focused solely on mobile services but expanded its offerings in 2018 with the acquisition of Com Hem, Sweden's largest cable company. Today, the company provides a comprehensive range of services, including mobile and fixed broadband, telephony, data network services, and cable TV, effectively challenging former government monopolies and established competitors. In Sweden, Tele2 holds the position of the second-largest telecom operator by market share. The company is recognized for its strong cost management and consistent dividend policy, which is expected to continue as it navigates the competitive telecom landscape.

Iren SpA, headquartered in Reggio Emilia, Italy, is a multi-utility company operating in the production, distribution, and sale of electricity, primarily from hydro, thermal, and cogeneration sources, as well as district heat and natural gas. It serves approximately 721,000 electricity and 743,000 gas customers through extensive networks. Additionally, Iren manages the integrated water cycle, including water distribution, sewerage, and treatment, serving around 2.8 million residents. The company also offers waste management services, including collection and disposal, and provides public administration services such as street lighting and traffic light systems.

XOCEAN Limited is a company that specializes in providing Data Collection-as-a-Service through its innovative uncrewed surface vessels (USVs). Founded in 2017 and based in Greenore, Ireland, XOCEAN focuses on delivering comprehensive ocean data solutions for surveyors, government bodies, and various offshore industries. The company's USVs are designed for unmanned operations over the horizon, utilizing satellite communications for real-time data acquisition, processing, and interpretation. XOCEAN also offers its CyberDeck, a secure cloud-based platform that enables remote monitoring and control of USVs, ensuring high-quality data collection while allowing adjustments to sensor parameters as needed. Their services encompass a range of applications, including seabed mapping, environmental monitoring, fisheries, bathymetry, and met ocean data. By leveraging proprietary technology, XOCEAN provides a safe, economical, and carbon-neutral approach to meeting the ocean data needs of its clients.

Wandercraft specializes in the development and sale of advanced exoskeletons that enable individuals with mobility impairments to walk independently. Its flagship product, Atalante, is the first exoskeleton designed for self-balanced walking, providing a realistic gait without the need for crutches or other aids. Since receiving CE-mark approval in 2019, Atalante has been utilized in European rehabilitation hospitals to assist with gait re-learning therapies. The company is also pursuing FDA approval for its technology. Additionally, Wandercraft is working on a more compact and agile Personal Mobility exoskeleton intended for everyday use. By integrating expertise in algorithmics, artificial intelligence, robotics, and clinical applications, Wandercraft aims to create innovative solutions that enhance the autonomy and quality of life for individuals with mobility challenges.

Intrinsic ID B.V. specializes in digital authentication solutions, primarily utilizing its proprietary SRAM Physical Unclonable Function (SRAM PUF) technology. Founded in 2008 and based in Eindhoven, the Netherlands, with operations in Korea, the company develops a range of products aimed at enhancing security for Internet of Things (IoT) and embedded applications. Its offerings include Broadkey, a secure key management software; Citadel, a key provisioning system; Quiddicard, which focuses on remotely programming keys; and Quiddikey, a solution for reconstructing on-chip secret keys without storage. These technologies are designed to validate payment systems, secure connectivity, authenticate sensors, and safeguard sensitive government and military data and systems.

Evonik Industries AG, headquartered in Germany, is a global specialty chemicals company. It operates in four major segments: specialty additives, smart materials, nutrition and care, and performance materials. Evonik produces and markets chemicals used in diverse industries, from automotive to pharmaceuticals, offering innovative solutions in areas such as animal nutrition, additives, smart materials, health care, and high-performance polymers. The company is a market leader in approximately 80% of its businesses and has a significant presence in Europe, North America, and Asia. Evonik Venture Capital, its corporate venture arm, invests in startups and venture capital funds with innovative technologies and high growth potential, focusing on areas such as resource efficiency, specialty additives, health & care, and nutrition.

Enel Green Power is a global leader in renewable energy, focusing on the development and management of power plants that utilize a diverse array of resources, including wind, solar, hydroelectric, geothermal, and biomass. Established in December 2008 as part of the Enel Group, the company operates across Europe and the Americas, boasting an installed capacity of 64.7 GW and generating approximately 25 terawatt-hours of electricity annually. This production supports the energy needs of over 8 million households and contributes to significant reductions in carbon emissions, avoiding around 16 million tonnes of CO2 each year. Enel Green Power emphasizes sustainability and innovation while actively collaborating with local communities to promote socio-economic development. The company is committed to expanding its installed capacity and enhancing technological mixes tailored to local conditions, thus playing a crucial role in the global transition to sustainable energy.

Northvolt AB, founded in 2016 and headquartered in Stockholm, Sweden, specializes in the manufacturing of sustainable lithium-ion batteries primarily for the renewable energy and transportation sectors. The company designs and produces a range of battery solutions, including cells, custom cells, and complete battery systems, tailored to meet specific requirements in terms of chemistry and form factor. Northvolt's commitment to sustainability is evident in its eco-friendly manufacturing processes, which ensure a minimal carbon footprint and incorporate advanced recycling technologies. By focusing on the development of high-quality, sustainable battery cells and systems, Northvolt aims to support the electrification of various markets, including automotive, grid storage, industrial applications, and micromobility, facilitating the transition away from fossil fuels towards cleaner energy sources.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies for patients with significant unmet medical needs, particularly in fibrosis, lysosomal storage disorders, and oncology. The company specializes in drugs that target nuclear receptors, transcription factors, and epigenetic modulation. Its primary product candidate, lanifibranor, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a condition currently lacking approved therapies. Inventiva has established a robust pipeline supported by a proprietary discovery engine, a dedicated research and development facility, and a skilled team with extensive experience in drug development. In addition to advancing lanifibranor, the company is also working on several earlier-stage programs aimed at addressing various medical conditions. All operations are conducted in France.

Metlen Energy & Metals SA, a global industrial and energy company, specializes in sustainable energy solutions and metallurgy. It operates in two primary segments: New Energy and Metallurgy. The New Energy segment, which contributes significantly to the company's revenue, focuses on power construction, gas trading, renewable energy, and energy storage. Geographically, a substantial portion of its revenue is generated in Hellas, with operations spanning forty countries worldwide. The company employs a synergistic approach, integrating its metallurgy and energy sectors to develop comprehensive energy infrastructure projects.

Zealand Pharma A/S is a biotechnology company based in Copenhagen, Denmark, specializing in the discovery and development of peptide-based medicines. The company has a growing proprietary pipeline that includes several clinical candidates such as glepaglutide for short bowel syndrome and dasiglucagon for diabetes management and congenital hyperinsulinism. Zealand's first developed medicine, lixisenatide, is a once-daily GLP-1 analogue for Type 2 diabetes, marketed globally outside the US. The company has established collaborations with major pharmaceutical partners, including Sanofi, Helsinn Healthcare, and Boehringer Ingelheim, enhancing its product offerings and expanding its reach in the market. Zealand Pharma is committed to advancing innovative therapies, with multiple projects in various stages of clinical development and preclinical research.

Exeger Sweden AB is a technology company that specializes in the development and commercialization of innovative light energy harvesting solutions. The company focuses on creating dye-sensitized solar cells that convert various forms of light, including both natural and artificial light, into electrical energy. This technology enables the integration of self-power capabilities into everyday devices, enhancing their functionality and sustainability. Exeger's solar cells can be printed in various colors and free-form designs, making them suitable for a wide range of applications in consumer electronics, wearables, and other products. By providing efficient energy solutions that operate even in indoor lighting conditions, Exeger aims to transform how energy is perceived and utilized in everyday life.

INBRAIN Neuroelectronics is a medical device company based in Barcelona, Spain, that specializes in developing graphene-based neural interfaces and intelligent neuromodulation systems aimed at treating brain disorders. Founded in 2019, the company offers the world's first brain-computer interface (BCI) therapeutics platform, which integrates precise BCI decoding with micrometric modulation to provide adaptive and personalized treatments for conditions such as Parkinson's disease, epilepsy, and stroke rehabilitation. Its technology enables continuous real-time monitoring and autonomous adjustments to therapy, enhancing therapeutic outcomes while reducing side effects. INBRAIN is also engaged in strategic collaborations, including with Merck KGaA, to expand its innovative solutions into peripheral nerve and systemic disease applications, thereby advancing the field of neurotechnology and bioelectronics.

Ericsson, established in 1876, is a global leader in telecommunications, providing technology and services to telecom operators worldwide. The company specializes in information and communications technology services, offering a broad portfolio that includes mobile and fixed network infrastructure, telecom services, software, broadband, and multimedia solutions. Ericsson Ventures, its investment arm, focuses on emerging growth areas such as IoT, AI, machine learning, and connected devices, managing over 95 million connected devices globally.

Energy Dome is an Italian company based in Lonate Pozzolo that specializes in long-duration electricity storage using liquid carbon dioxide. The company has developed a low-cost and efficient technology that employs a closed-loop thermodynamic process to store energy, making renewable power more dispatchable. By focusing on energy storage solutions, Energy Dome aims to facilitate the transition to renewable energy and contribute to the decarbonization of the energy industry. Its innovative approach seeks to address climate change challenges by significantly reducing greenhouse gas emissions, thereby promoting a more sustainable future.

Antibiotice S.A. is a Romanian pharmaceutical company that specializes in the development and manufacturing of generic drugs. Established in 1955 and headquartered in Iasi, the firm offers a diverse portfolio of approximately 150 medicines across 12 therapeutic classes, including cardiovascular, central nervous system, digestive tract, anti-inflammatory, dermatological, oncological, and pain management medications. In addition to human medicines, the company produces veterinary drugs and the active pharmaceutical ingredient Nystatin. Antibiotice's product forms include sterile injectable powders, capsules, tablets, ointments, gels, creams, suppositories, and pessaries. The company exports its products to around 75 countries, reflecting its commitment to addressing a wide range of health needs globally.

Hellenic Electricity Distribution Network Operator is responsible for providing electricity to approximately 7.5 million consumers across Greece. Based in Athens, the organization manages a vast network comprising 240,000 kilometers of medium and low voltage power lines. Its core functions include the maintenance and development of the electricity distribution network, ensuring transparent access for all consumers and network users. By focusing on reliability and economic efficiency in power supply, the operator aims to enhance the quality of life for citizens and support their welfare.

Amplifon is a leading international provider of hearing care solutions and services, dedicated to helping individuals rediscover the joys of sound. The company offers a wide range of customizable hearing products that are tailored to meet the unique needs of consumers. Amplifon operates through a comprehensive distribution network that includes corporate shops, franchises, and shop-in-shops, allowing it to reach various markets effectively. It has a significant presence in the EMEA region, which accounts for most of its revenue, while also having a footprint in the Americas and Asia-Pacific. Amplifon markets its offerings under several brands, including Amplifon, Beter Horen, Maxtone, and Miracle-Ear, with a notable concentration of retail locations in Italy. Through its commitment to innovative technology and personalized service, Amplifon strives to deliver the highest quality hearing care experience to its customers.

VoltStorage GmbH, based in Olching, Germany, specializes in developing and producing power storage devices that utilize eco-friendly redox flow technology. The company's flagship product, VoltStorage, is a vanadium redox flow battery system designed to store excess electricity generated by solar panels during the day for use at night. This innovative approach enables homeowners to access renewable energy around the clock, promoting sustainability and environmental responsibility. In addition to its products, VoltStorage offers installation and technical support services, ensuring customers can effectively integrate these systems into their homes. The company aims to make renewable energy more accessible and contribute to a cleaner, fairer world for future generations.

Endesa is an electric utility company headquartered in Madrid, Spain, that generates, distributes, and supplies electricity primarily in Spain and Portugal. Founded in 1944, the company has an installed generation capacity of 22 gigawatts, utilizing a diverse mix of energy sources, including hydroelectric, nuclear, coal, natural gas, oil, solar, and wind. Endesa serves approximately 11.2 million customers and employs over 10,000 people. In addition to its core electricity services, Endesa operates in the natural gas sector and provides energy-related services, emphasizing a commitment to sustainability and technological innovation to address current and future energy challenges. The company also supplies gas to retail and business customers in Spain and France.

University College Cork is a prominent higher education institution located in Cork, Ireland, established in 1845. The university offers a diverse range of courses, encompassing fields such as Accounting, Zoology, and many others, catering to a broad spectrum of academic interests. Positioned dramatically on a limestone bluff, the campus provides an inspiring environment for students. University College Cork aims to address the evolving needs of higher education in Ireland, reflecting its commitment to fostering academic development and innovation. The institution's assets are overseen by a dedicated executive management team, ensuring effective governance and operational efficiency.

Garanti BBVA Romania is a dynamic bank in the local market, offering a comprehensive range of banking and financial services to clients in Bucharest. The bank provides quality products for various sectors, including retail, small and medium-sized enterprises (IMM), and corporate clients. Its services encompass debit cards, bank accounts, loans, financing solutions, financial risk protection, and payment systems, effectively catering to the needs of both individuals and businesses.

Trucksters is a Madrid-based freight startup that provides long-haul transport services through a unique relay system. This innovative approach utilizes big data and artificial intelligence to enhance the efficiency of long-distance road transit. By implementing relays, Trucksters enables trucks to remain in continuous motion, significantly reducing delivery times and transportation costs. The company operates throughout the European Union and serves over 500 shippers, contributing to the electrification agenda and improving the working conditions for drivers. Through its advanced logistics solutions, Trucksters aims to optimize the global road freight industry.

Wingcopter GmbH, founded in 2014 and based in Darmstadt, Germany, specializes in the development and manufacture of advanced delivery drones for various applications, including medical supply chains and last-mile logistics. The company produces eVTOL, fixed-wing unmanned aircraft systems designed to efficiently deliver medicines, vaccines, blood, lab samples, parcels, and food to remote locations, as well as conduct inspections of public infrastructure. Its flagship model, the Wingcopter 198, features a patented tilt-rotor mechanism that allows for vertical takeoff and landing while maintaining the efficiency and range of a fixed-wing aircraft, even under challenging weather conditions. With a dedicated team of 120 professionals, Wingcopter aims to enhance and save lives through both commercial and humanitarian efforts, earning recognition as a Technology Pioneer by the World Economic Forum in 2020.

AT&S is a European manufacturer of printed circuit boards, specializing in high-end technology. The company provides a diverse array of printed circuit boards tailored to meet specific customer requirements, including double-sided plated-through, multi-layer, high-density interconnection, laser-drilled insulated metallic substrates, flexible, rigid-flex, and semi-flexible options. AT&S serves various core markets, such as mobile devices, automotive, industrial, medical, aviation, and advanced packaging. With a workforce of approximately 7,300 employees, including around 1,200 in Austria, AT&S is headquartered in Leoben, Austria. The company has demonstrated notable financial performance, achieving significant sales revenues in recent years.

TIM, or Telecom Italia Mobile, is a prominent Italian telecommunications company and a key player in the telephony sector in Italy. It is part of the Telecom Italia Group and also has a significant presence in Brazil through TIM Brasil. The company focuses on offering a range of telecommunications services, including mobile and fixed-line communications, aiming to meet the needs of both individual and business customers. TIM is dedicated to advancing connectivity and technology in the regions it serves, with an emphasis on enhancing digital life and telecommunications infrastructure.

Smart Reporting GmbH is a Munich-based company that specializes in providing a digital health solution for structured medical reporting, particularly in the fields of radiology and pathology. Established in 2014, the company offers an online platform that enables radiologists to generate high-quality medical reports through intelligent software that adheres to guideline-compliant criteria. The platform facilitates the creation of report templates, automatic text suggestions, and integration with hospital systems, thereby enhancing the efficiency and quality of medical reporting. Additionally, Smart Reporting provides tools for hospitals and practices to implement reporting standards, optimize templates, and ensure consistent report appearance across various physicians. The company also supports medical registries and clinical studies with solutions for structured reporting, data collection, and multilingual capabilities, all aimed at improving communication and quality assurance in medical documentation.

Illimity Bank, founded in 2018 and headquartered in Milan, Italy, is a commercial bank that delivers digital direct banking services to both retail and business clients. The bank specializes in providing corporate credit, managing non-performing loan (NPL) portfolios, and offering financing solutions specifically tailored for small and medium-sized enterprises (SMEs). Additionally, Illimity Bank engages in investment banking activities, including the establishment and management of investment funds and facilitating initial public offerings. With a focus on addressing the challenges posed by distressed credit and the increasing prevalence of bad loans, Illimity Bank aims to support its clients through innovative financial solutions.

SiPearl is a French semiconductor company established in 2019, headquartered in Maisons-Laffitte, Île-de-France, with research and development centers located in France, Germany, and Spain. The company specializes in the design of high-performance, low-power microprocessors intended for exascale supercomputers, aligning its product development with the European Union’s technological goals. Its first microprocessor range, Rhea, is set for commercialization in early 2024 and is based on the Arm Neoverse V1 architecture. SiPearl is committed to manufacturing Rhea using advanced processes from TSMC, ensuring state-of-the-art performance. The microprocessors are aimed at a variety of applications, including computing, artificial intelligence, medical research, climate change mitigation, and energy management, serving scientific researchers and major players in the IT, electronics, and automotive sectors.

Reden Solar specializes in the development, financing, construction, and operation of solar photovoltaic power plants across Europe and Latin America. With an installed portfolio of 762 megawatts and an additional 15 gigawatts under development, the company primarily focuses on markets in France and Spain, while also expanding its operations in Greece and Italy. Reden Solar provides a variety of photovoltaic solutions, including agricultural greenhouses, ground-mounted systems, shelters, and rooftop installations, aimed at promoting sustainable energy production and contributing to environmental conservation.

GeNeuro is a biotechnology company based in Plan-Les-Ouates, Switzerland, specializing in the development of therapeutic drugs for diseases linked to pathogenic proteins originating from human endogenous retroviruses. The company primarily targets nervous system disorders, including multiple sclerosis and schizophrenia. Its lead product, GNbAC1, is a therapeutic monoclonal antibody designed to treat multiple sclerosis, while temelimab is another candidate that neutralizes a pathogenic protein from the HERV-W family. Additionally, GeNeuro is engaged in developing diagnostic tests to measure multiple sclerosis-associated retrovirus-ENV proteins in patients. Founded in 2006, the company is committed to addressing the underlying factors that drive the progression of neurodegenerative and autoimmune diseases.

Orange is a global telecommunications company, founded in 1991 and headquartered in Paris, France. It operates in 30 countries across Europe and Africa, providing mobile and internet services to consumers, and corporate telecommunication services worldwide. Through its business arm, Orange Business Services, it caters to large corporates, local authorities, and SMEs, offering a comprehensive range of voice and data, IT, and integrated services. Additionally, Orange supports digital innovation through its international network of startup accelerators, Orange Fabs, which provides resources and expertise to startups in the digital space.

AB Science is a France-based pharmaceutical company founded in 2001 by a team of researchers, clinicians, and entrepreneurs. It specializes in the research, discovery, development, and marketing of protein kinase inhibitors, focusing on targeted therapies using tyrosine kinase inhibitors. The company aims to address significant unmet medical needs in various fields, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases. AB Science is committed to innovating and developing new drugs that can significantly improve the lives of patients and enhance treatment outcomes in both human and veterinary medicine.

Independent Power Transmission Operator (IPTO or ADMIE) operates the Transmission System of Greece's Electricity Transmission System. Therefore, IPTO ensures the electricity supply to Greece is adequately, safely, efficiently, and reliably handled in accordance with its operational, control, maintenance, and development duties. Additionally, IPTO operates the Greek electricity market according to the principles of transparency, equality and free competition

Power Capital Renewable Energy Limited, founded in 2011 and based in Dublin, Ireland, focuses on the development, operation, and management of large-scale photovoltaic solar farms. The company specializes in all four stages of a solar asset's life cycle, including design, development, financing, construction, and operation. By acquiring and managing utility-scale solar parks, Power Capital aims to provide clean and reliable energy, contributing to the sustainability of the renewable energy sector. Their commitment to delivering competitive and sustainable energy solutions positions them as a significant player in the renewable energy market.

ExeVir Bio BV, founded in 2020 and based in Zwijnaarde, Belgium, specializes in developing single-domain antibody-based therapies aimed at combating viral infections. The company leverages a llama-derived antibody technology platform to create robust antiviral treatments that offer broad protection against coronaviruses. Notably, it is developing VHH72-FC, an antibody that targets a highly conserved region on the spikes of SARS-CoV-2, crucial for the virus's entry into human cells. ExeVir Bio's rapid response platform for antivirals allows for an agile approach to emerging health threats, enabling the swift generation of drug candidates. The therapeutics produced through this innovative technology are designed to be stable, cost-effective, and accessible on a global scale.

Cellectis S.A. is a clinical-stage biotechnological company based in Paris, France, focused on developing innovative immuno-oncology therapies using gene-edited T-cells. The company specializes in allogeneic Chimeric Antigen Receptor T-cell (CAR-T) products, with a portfolio that includes several product candidates targeting various hematologic malignancies. Notable candidates include UCART19, aimed at treating CD19-expressing hematologic cancers such as acute lymphoblastic leukemia; UCART123 for acute myeloid leukemia; and UCARTCS1 and ALLO-715 for multiple myeloma. In addition to its therapeutic efforts, Cellectis also produces high oleic soybean oil and other soybean products, as well as fiber wheat. The company collaborates with various strategic partners, including Allogene Therapeutics and The University of Texas M.D. Anderson Cancer Center. Founded in 1999, Cellectis continues to advance its mission of eradicating cancer through cutting-edge gene-editing technologies.

Affibody is a Swedish biotech company dedicated to developing innovative products for therapy and diagnostic imaging through its proprietary technology platforms, including Affibody® molecules and Albumod™. These small, robust molecules can be engineered to bind specifically to a wide array of target proteins, offering diverse applications in protein purification, enzyme inhibition, and research reagents for protein detection. The company is also focused on advancing protein-based drugs and monoclonal antibodies aimed at treating conditions such as psoriasis and autoimmune diseases. By doing so, Affibody aims to provide effective therapies that enhance the quality of life for patients suffering from serious medical conditions.

AB Science is a France-based pharmaceutical company founded in 2001 by a team of researchers, clinicians, and entrepreneurs. It specializes in the research, discovery, development, and marketing of protein kinase inhibitors, focusing on targeted therapies using tyrosine kinase inhibitors. The company aims to address significant unmet medical needs in various fields, including cancer, chronic inflammatory diseases, neurological degenerative disorders, and central nervous system diseases. AB Science is committed to innovating and developing new drugs that can significantly improve the lives of patients and enhance treatment outcomes in both human and veterinary medicine.

numares AG is a German company specializing in the development and marketing of software-based test systems for clinical diagnostics and life science research. Founded in 2004 and based in Regensburg, the company utilizes nuclear magnetic resonance (NMR) spectroscopy and machine learning to analyze metabolomic networks. Its AXINON in vitro diagnostic system produces numeric spectra that provide critical information regarding patients' disease statuses, particularly in the fields of cardiovascular diseases, nephrology, oncology, and neurology. By employing magnetic group signaling (MGS) technology, numares AG offers a reliable, efficient, and cost-effective solution for NMR-based diagnostics, positioning itself as a leader in commercial NMR analytics in Europe while providing expert support to its customers.

LeydenJar Technologies B.V. is a Netherlands-based company founded in 2016 that focuses on enhancing lithium-ion battery performance through the development of pure silicon anodes. By replacing traditional graphite anodes with innovative nanoporous silicon, LeydenJar Technologies significantly increases energy density, achieving a 70% improvement over current standards. This advancement not only leads to batteries with higher energy density of 1350Wh/L but also reduces costs by 20% and lowers the carbon footprint by 85%. The company's commitment to greener, more efficient battery technology positions it as a key player in the energy storage market.

Advicenne is a late-stage biopharmaceutical company founded in 2007 and headquartered in Nîmes, France. The company focuses on developing and commercializing innovative treatments for unmet medical needs in nephrology, particularly targeting orphan renal diseases and niche neurology indications. Its lead drug candidate, ADV7103, is undergoing late-stage clinical trials for two specific conditions: distal renal tubular acidosis (dRTA) and cystinuria. Advicenne aims to create pediatric-friendly therapeutics that enhance the lives of patients from early childhood through adulthood.

GomSpace is a Danish space company founded in 2007 that specializes in the development and commercialization of nano-satellites. It offers turn-key solutions for various applications, including Internet of Things (IoT), communication, tracking, surveillance, and remote sensing. GomSpace provides a range of products such as professional nano-satellite solutions, commercial off-the-shelf sub-systems, software modules, and customizable payloads designed to meet specific customer requirements. The company operates across diverse sectors, including academia, commercial enterprises, defense, and scientific research, with a global presence that extends to Europe, the United States, Asia, and beyond. Through its innovative approach to nanosatellite technology, GomSpace aims to facilitate the growth of space-based businesses and services.

OVH APAC is a leading cloud provider known for its innovative and cost-effective solutions tailored for a diverse clientele, ranging from startups to large enterprises. Founded in 1999 by Octave Klaba and based in France, OVH offers a comprehensive portfolio of services, including web hosting, dedicated servers, cloud solutions, domain registration, and VOIP telephony. The company distinguishes itself through its proprietary global fiber-optic network and green data centers, which enable optimal performance and reliability. With a commitment to research and development and complete control over its supply chain, OVH delivers high-quality products and exceptional customer service. Additionally, OVH has established a strong partnership with VMware, integrating advanced software solutions to enhance network performance and streamline service delivery for its customers. As a result, OVH is recognized as one of the top internet hosting companies globally, serving millions of customers with cutting-edge technology and expertise.

The International Fund for Agricultural Development (IFAD) is a United Nations agency established in 1977 and headquartered in Rome, Italy. It focuses on agricultural development in developing countries by providing grants and low-interest loans to rural projects. IFAD aims to empower rural populations to enhance food security, improve nutrition, and increase their incomes. In addition to financing sovereign governments, IFAD has adopted a private sector investment strategy to support small and medium-sized enterprises, cooperatives, and smallholder farmers. This approach allows IFAD to fund a diverse range of initiatives that boost productivity, promote climate-smart practices, and foster resilience among rural communities. By attracting private sector funding, IFAD expands its capacity to contribute to sustainable agricultural development and poverty reduction in rural areas.

Energiefonds Overijssel is a venture capital firm established in 2012 and located in Zwolle, Netherlands. The company is dedicated to supporting the energy transition by providing financial contributions to initiatives and businesses that focus on energy savings or the generation of energy from renewable sources. Backed by the government, Energiefonds Overijssel prioritizes investments in renewable energy and clean energy technology, aiming to foster sustainable practices and innovation within the energy sector.

GenSight Biologics S.A. is a clinical-stage biotechnology company based in Paris, France, focused on developing gene therapy treatments for retinal degenerative diseases and neurodegenerative conditions affecting the central nervous system. Utilizing its core technology platforms—Mitochondrial Targeting Sequence and Optogenetics—the company aims to preserve and restore vision in patients with severe retinal disorders. Its lead product candidates include GS010, an AAV2-based gene therapy currently in Phase III trials for treating Leber hereditary optic neuropathy caused by mutations in the ND4 gene, and GS030, which is undergoing Phase I/II trials for retinitis pigmentosa and geographic atrophy in dry age-related macular degeneration. In addition to these, GenSight is advancing several products in preclinical stages targeting various ophthalmic and neurodegenerative diseases. Founded in 2012, the company is dedicated to innovative approaches that aim to prevent vision loss and improve the quality of life for affected patients.

SpinDiag GmbH is a medical technology company based in Freiburg, Germany, focused on developing automated point-of-care systems for the rapid and reliable detection of infectious diseases. Founded in 2016, the company has created a centrifugal-microfluidic test system that allows healthcare providers to screen for the 25 most common antibiotic resistances directly from patient samples upon hospital admission. This innovative system helps prevent the spread of drug-resistant bacteria by enabling the immediate isolation of infected patients. SpinDiag's first product is an automated SARS-CoV-2 test that provides laboratory-grade PCR results directly from standard patient swab samples, streamlining the workflow for nurses and integrating seamlessly into clinical practice. The fully automated system eliminates the need for manual pipetting, thereby minimizing the risk of infection and enhancing the efficiency of pathogen detection in hospital settings.

MithraSol specialises in the identification, development, construction and operation of Spanish solar photovoltaic assets and currently has 50MW of assets in development across twelve projects spanning central and southern Spain.

Aquila Capital is a private investment firm based in Hamburg, Germany, founded in 2001. It specializes in providing institutional investors, pension funds, foundations, and individuals with alternative investment solutions across real assets, financial markets, and private equity. The firm employs a multi-disciplinary investment approach, leveraging a team of dedicated specialists to manage a diverse range of investments, including hedge funds, private equity fund of funds, real estate, and infrastructure projects. Aquila Capital emphasizes strong operational frameworks and corporate governance to enhance its investment management capabilities. The firm operates additional offices in Frankfurt, Munich, and Vienna, and aims to identify and manage attractive investment opportunities for its clients through a solution-oriented approach that encompasses strategy development, implementation, and asset management.

Blickfeld GmbH, established in 2017 and based in Munich, Germany, specializes in the production of LiDAR sensors and associated software. These sensors, based on patented silicon MEMS mirrors and commercial off-the-shelf components, measure direct distance information in 3D, enabling autonomous vehicles to perceive and analyze their surroundings. The company's object detection and mapping software processes data from these sensors, facilitating applications in city planning, connected mobility, real-time mapping, and usage pattern analysis. Blickfeld caters to the automotive, transportation, industrial, and robotics sectors, offering low-cost LiDAR systems to support the mass market's transition towards autonomous mobility and IoT applications.

Loci Orthopaedics Limited, based in Upper Newcastle, Ireland, specializes in developing innovative medical technologies to address significant unmet clinical needs in orthopedics. Founded in 2017, the company focuses on creating surgical implants, particularly the InDx implant, which is designed to treat arthritis in the thumb base joint. This implant uniquely mimics the natural motions of the thumb joint, offering a less invasive and easier insertion method compared to existing surgical options. Additionally, Loci Orthopaedics is known for its Osteoanchor surface architecture, which is based on evidence-based designs, enabling clinicians to effectively address challenges in orthopedic extremities.

Nomagic, Inc. is a company based in Warsaw, Poland, specializing in robotic manipulation solutions for order fulfillment in e-commerce warehouses. By providing smart pick-and-place robotic systems, Nomagic enhances efficiency, flexibility, and reliability in the logistics process. Their technology automates repetitive tasks, reduces fulfillment costs, and addresses labor shortages, allowing warehouses to operate seamlessly around the clock. The company's robots have already been implemented on packing lines at Cdiscount, a leading French e-commerce platform. Utilizing artificial intelligence, Nomagic's systems continuously learn and adapt to changing conditions, improving the agility of warehouse operations and ensuring reliable delivery of goods.

Sensible4 is an autonomous driving software company based in Espoo, Southern Finland, founded in 2017. The company specializes in developing self-driving vehicle technology that operates effectively in all weather conditions and does not rely on lane markings. Sensible4 offers its expertise to vehicle manufacturers, automotive suppliers, cities, and mobile operators, enabling them to implement autonomous transport solutions, including shuttles and delivery vehicles. Their software platform utilizes AI sensor fusion to ensure safe and efficient operations while consuming minimal energy and resources. Sensible4 aims to integrate self-driving shuttle fleets into existing urban transportation systems, enhancing last-mile connectivity for goods and passengers.

Inventiva Pharma is a clinical-stage biopharmaceutical company based in France, dedicated to developing oral small molecule therapies for patients with significant unmet medical needs, particularly in fibrosis, lysosomal storage disorders, and oncology. The company specializes in drugs that target nuclear receptors, transcription factors, and epigenetic modulation. Its primary product candidate, lanifibranor, is being developed for the treatment of non-alcoholic steatohepatitis (NASH), a condition currently lacking approved therapies. Inventiva has established a robust pipeline supported by a proprietary discovery engine, a dedicated research and development facility, and a skilled team with extensive experience in drug development. In addition to advancing lanifibranor, the company is also working on several earlier-stage programs aimed at addressing various medical conditions. All operations are conducted in France.

Cabify, established in 2011 and based in Madrid, Spain, is a ride-sharing company that facilitates transportation for both individuals and businesses. It offers a user-friendly web and mobile app for booking rides, connecting users with suitable transport options. Cabify prioritizes customer satisfaction, ensuring fair pricing, comfortable journeys, and accessibility for all. Its services include clean, modern vehicles driven by trained professionals, providing safe and reliable rides with added amenities like music and magazines. The company aims to enhance urban mobility and improve cities and communities by making transportation better.

IQM Quantum Computers, founded in 2018 and headquartered in Espoo, Finland, specializes in developing and manufacturing hardware systems for quantum computing. The company focuses on scalable hardware solutions utilizing superconducting technology to build quantum processors for universal quantum computers. By concentrating on practical applications, IQM aims to enhance quantum computing capabilities and address challenges faced by various industries and society. As a spin-out from Aalto University and the VTT Technical Research Centre of Finland, IQM has achieved significant advancements in areas such as thermal management, which are crucial for improving computational speed and information accuracy. The company's innovations position it as a leader in the global pursuit of large-scale quantum computing solutions. IQM also offers access to its hardware for research laboratories and supercomputing centers, helping businesses reduce error rates that currently limit computing performance.

Airborne International is engaged in engineering, manufacturing, and supplying high-end composites structures for industries such as aerospace, defense, marine, high-end bicycles, and formula-one cars. It offers composites structures maintenance and repair services, including inspection and damage assessment, sealing and painting, and balancing. The company was founded in 1995 and is based in The Hague, the Netherlands.

InstaFreight GmbH is a Berlin-based company that specializes in providing online freight forwarding services to B2B customers. Founded in 2016, InstaFreight aims to simplify the booking and processing of freight transport, making it fast and straightforward for businesses. The company focuses on delivering reliability, quality, and transparency, striving to become Europe's leading online freight forwarder. By offering innovative solutions and exceptional service, InstaFreight reduces the complexity of supply chains and enhances transparency for both customers and carriers.

Priothera Ltd is a clinical-stage company based in Dublin, Ireland, with an additional location in Saint Louis, France. It specializes in the development of orally applied sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. The company's primary focus is on its lead product, mocravimod, which is designed to enhance the curative potential of allogeneic haematopoietic stem cell transplants. By reducing the egress of T cell subsets from lymphatic tissues, Priothera's modulators aim to provide dual inhibition of graft versus host disease while also promoting graft versus leukemia effects, ultimately improving patient outcomes in this challenging area of medicine.

TRUMPF, a German high-technology company, is a global leader in manufacturing sheet metal fabrication machinery, industrial lasers, and medical technologies. It offers a wide range of production solutions, including laser cutting, welding, and marking systems, as well as punching and additive production equipment. TRUMPF Venture, established in 2016, is the company's corporate venture capital arm, investing in early-stage startups that operate in areas complementary or adjacent to TRUMPF's core business, such as advanced photonics and smart factories. The venture capital arm seeks innovative technologies and business models, and provides funded startups with access to its extensive network, deep domain expertise, and support for scaling and market entry. TRUMPF, as an independent, family-owned company, focuses on long-term strategies and continuous innovation to drive digital connectivity in manufacturing.

DyeMansion GmbH, established in Munich, Germany in 2013, specializes in post-processing and coloring of 3D-printed laser sintered parts. The company offers high-volume finishing systems that transform raw, 3D-printed parts into high-value consumer and industrial products, such as eyewear, automotive components, and medical devices. DyeMansion works with major 3D printing systems like EOS, HP, and 3D Systems, enabling precision coloring and finish to exact specifications. With over 400 customers, including leading global manufacturers, DyeMansion has become the global leader in additive manufacturing finishing systems for 3D-printed polymer parts.

DPG Media Group is a media company based in Antwerp, Belgium, specializing in the publication of newspapers, journals, and magazines. It provides a diverse array of news coverage, including entertainment, sports, politics, and market-related stories. In addition to its publishing activities, DPG Media offers advertising services to its clients, catering to a wide audience across Belgium. The company's content encompasses social, scientific, economic, and commercial topics, ensuring a comprehensive approach to media and information dissemination.

Essity is a hygiene and health company based in Stockholm, Sweden, founded in 2017. It develops, produces, and sells a range of personal care products including feminine care, baby care, toilet paper, facial tissue, wet wipes, hand soap, hand sanitizers, and tissue dispensers for institutional customers. Additionally, Essity offers medical solutions such as wound care, orthopedics, and compression therapy. The company operates in 150 markets worldwide, with a significant portion of its revenue generated in Europe.

miDiagnostics is a Belgian company focused on creating innovative, chip-based technology for self-administered blood analysis. The company is developing a new generation of disposable tests that require only small drops of blood, allowing for the detection of various biomarkers, including cells, proteins, nucleic acids, and small molecules. Their technology integrates a nanofluidic processor on a chip with a compact reader, facilitating lab-quality diagnostics from easy-to-access samples like finger-prick blood or nasal swabs. This approach enables both patients and clinicians to conduct rapid diagnostics conveniently and efficiently, regardless of location.

Sato is a Finnish company based in Helsinki, operating an online platform that connects users with rental apartments.

Stilla Technologies is a biotechnology company based in Villejuif, France, with an additional location in Beverly, Massachusetts. Founded in 2013, the company specializes in accelerating the development of next-generation genetic tests through its innovative digital PCR (dPCR) solution, the Naica System. This platform leverages advanced microfluidic technology to provide a flexible and accessible tool for high-resolution genetic analysis. By enabling compatibility with multiple chemistries and offering multiplex capabilities, Stilla Technologies aims to simplify the processes of image analysis and data exploration for researchers in various fields, including life sciences and therapeutics. The company's mission is to make digital PCR a standard tool across all areas of genetic research and application.

Xeltis AG, established in 2006, is a clinical-stage medical device company based in Zurich, Switzerland, with additional operations in the Netherlands and the USA. The company specializes in developing bio-absorbable heart valves and blood vessels, utilizing a proprietary polymer-based technology called RestoreX. This technology enables the patient's natural healing system to develop tissue that permeates the heart valve, forming a new functional valve within it through a therapeutic approach called Endogenous Tissue Restoration (ETR). Xeltis' restorative devices include implantable small diameter blood vessels for hemodialysis vascular access and coronary artery bypass graft (CABG) surgery, as well as pulmonary heart valves, with ongoing clinical trials. The company has secured significant funding from investors such as EQT Life Sciences, Kurma Partners, and the European Investment Bank, totaling over €30 million.

University College Dublin (UCD), founded in 1854, is a prominent research-intensive university located in Ireland. It is the largest and most diverse university in the country, with a student population exceeding 30,000 from around 124 nations. UCD provides a broad range of undergraduate and graduate programs, including fields such as accounting and biology. The institution emphasizes an innovative and flexible educational experience through its UCD Horizons curriculum, catering to the intellectual and personal development of students. UCD is particularly recognized for its graduate education, hosting approximately 7,000 graduate students and nearly 2,000 PhD candidates, with over half of its undergraduates continuing to pursue advanced studies. Through its commitment to research, innovation, and community engagement, UCD plays a vital role in fostering academic excellence and development in Ireland.

Infrastrutture Wireless Italiane S.p.A., established in Milan, Italy, specializes in constructing, operating, and managing wireless network infrastructure across Italy. The company hosts transmission equipment for major operators on its approximately 23,000 sites, contributing significantly to national wireless telephony coverage. It offers integrated hosting services including antenna framework, cabling, power supply systems, site management, maintenance, and fiber optic connections. Additionally, Infrastrutture Wireless Italiane designs and constructs new sites and creates indoor/outdoor coverage using micro cells and distributed antenna systems for various locations such as stations, hospitals, and stadiums. Its primary competitor is Cellnex.